Sanofi says reaches patent deal with Eli Lilly on Lantus SoloSTAR

PARIS, Sept 28 (Reuters) - Sanofi and Eli Lilly have reached a deal putting an end to a patent infringement lawsuit on Sanofi's Lantus SoloSTAR, Sanofi said in a statement on Monday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.